A detailed history of Rappaport Reiches Capital Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Rappaport Reiches Capital Management, LLC holds 8,746 shares of ABT stock, worth $1.01 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
8,746
Previous 8,740 0.07%
Holding current value
$1.01 Million
Previous $908 Million 9.8%
% of portfolio
0.27%
Previous 0.27%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$100.07 - $118.13 $600 - $708
6 Added 0.07%
8,746 $997 Million
Q2 2024

Jul 18, 2024

SELL
$100.73 - $112.44 $914,326 - $1.02 Million
-9,077 Reduced 50.95%
8,740 $908 Million
Q1 2024

Apr 16, 2024

BUY
$109.52 - $120.96 $605,645 - $668,908
5,530 Added 45.01%
17,817 $2.03 Billion
Q4 2023

Jan 24, 2024

BUY
$90.19 - $110.4 $8,477 - $10,377
94 Added 0.77%
12,287 $1.35 Billion
Q3 2023

Oct 10, 2023

SELL
$95.53 - $114.62 $95 - $114
-1 Reduced 0.01%
12,193 $1.18 Billion
Q2 2023

Aug 23, 2023

SELL
$100.78 - $112.29 $42,629 - $47,498
-423 Reduced 3.35%
12,194 $1.33 Billion
Q1 2023

Aug 23, 2023

SELL
$96.86 - $114.01 $50,754 - $59,741
-524 Reduced 3.99%
12,617 $1.28 Billion
Q4 2022

Aug 23, 2023

SELL
$95.06 - $111.52 $95,155 - $111,631
-1,001 Reduced 7.08%
13,141 $1.44 Billion
Q3 2022

Aug 23, 2023

SELL
$96.76 - $112.03 $11,224 - $12,995
-116 Reduced 0.81%
14,142 $1.37 Billion
Q2 2022

Aug 23, 2023

BUY
$102.07 - $123.37 $25,517 - $30,842
250 Added 1.78%
14,258 $1.55 Billion
Q1 2022

Aug 23, 2023

BUY
$114.02 - $139.04 $92,356 - $112,622
810 Added 6.14%
14,008 $1.66 Billion
Q4 2021

Aug 23, 2023

BUY
$115.53 - $141.46 $786,990 - $963,625
6,812 Added 106.67%
13,198 $1.86 Billion
Q3 2021

Aug 23, 2023

SELL
$116.66 - $129.06 $32,198 - $35,620
-276 Reduced 4.14%
6,386 $754 Million
Q2 2021

Aug 22, 2023

BUY
$105.79 - $124.53 $704,772 - $829,618
6,662 New
6,662 $772 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Rappaport Reiches Capital Management, LLC Portfolio

Follow Rappaport Reiches Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rappaport Reiches Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rappaport Reiches Capital Management, LLC with notifications on news.